MedPath

Bioprojet Pharma

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

25

Active:15
Completed:4

Trial Phases

3 Phases

Phase 1:22
Phase 2:1
Phase 3:1

Drug Approvals

17

CIMA_AEMPS:10
NMPA:5
EMA:2

Drug Approvals

Pitolisant Hydrochloride Tablets

Product Name
盐酸替洛利生片
Approval Number
国药准字HJ20230088
Approval Date
Jun 30, 2023
NMPA

Pitolisant Hydrochloride Tablets

Product Name
盐酸替洛利生片
Approval Number
国药准字HJ20230087
Approval Date
Jun 30, 2023
NMPA

Racecadotril Powder

Product Name
消旋卡多曲散
Approval Number
H20150251
Approval Date
Apr 29, 2020
NMPA

Racecadotril Powder

Product Name
消旋卡多曲散
Approval Number
H20150250
Approval Date
Apr 29, 2020
NMPA

Racecadotril Capsules

Product Name
消旋卡多曲胶囊
Approval Number
H20130353
Approval Date
Dec 27, 2019
NMPA

Clinical Trials

Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials

Phase 1
22 (91.7%)
Phase 2
1 (4.2%)
Phase 3
1 (4.2%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.